Related Experiment Video
Updated: Nov 12, 2025
A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats
Published on: November 6, 2019
Scopoletin Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Improves Neurological Performance in Rats
Wanzeng Zhang1, Wangmiao Zhao1, Chunyan Ge1
1Department of Neurosurgery, Harrison International Peace Hospital Affiliated to Hebei Medical University, Hengshui City, China.
Insights
Scopoletin shows promise in protecting against brain injury from intracerebral hemorrhage (ICH). This natural compound reduced neurological deficits and brain swelling in rats, suggesting potential for new ICH treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Intracerebral hemorrhage (ICH) is a severe stroke complication with high mortality and no effective treatments.
- ICH leads to significant disability and death, necessitating urgent therapeutic strategies.
Purpose of the Study:
- To evaluate the neuroprotective effects of scopoletin against ICH-induced brain injury.
- To assess scopoletin's potential as a therapeutic agent for stroke.
Main Methods:
- Wistar male rats were divided into control, ICH-induced, scopoletin-pretreated ICH, and scopoletin control groups.
- Neurobehavioral outcomes, cerebral edema, and neuroinflammation markers (TREM-1, SERPINE-1, TNF-α, IL-1β, IL-13, IL-17) were assessed using RT-PCR and biochemical analyses.
Main Results:
- Scopoletin treatment significantly reduced neurological deficits and markers of neurodegeneration in ICH rats.
- The compound attenuated cerebral edema and normalized elevated inflammatory cytokine levels (TNF-α, IL-1β, IL-13, IL-17) in the brain.
- Scopoletin administration restored biochemical parameters closer to normal levels compared to untreated ICH animals.
Conclusions:
- Scopoletin demonstrates significant efficacy in improving acute neurological function following ICH.
- The findings suggest scopoletin is a promising lead molecule for developing novel therapeutic interventions for intracerebral hemorrhage.
Background:
Among the hypertension-related complications, the onset of intracerebral hemorrhage (ICH) is a destructive stage and is the most disabling type of stroke that has the highest death rate. At present, there is no promising treatment for ICH.
Objectives:
The present investigation was aimed at evaluating the safeguarding effect of scopoletin against ICH-induced brain injury.
Methods:
We used Wistar male rats and divided them into 4 groups. Group 1 served as control, group 2 was induced with ICH, group 3 served as scopoletin-pretreated ICH rats, and group 4 as scopoletin drug control. During the experimental period, neurobehavioral outcome, cerebral edema, and neuroinflammation parameters were evaluated using RT-PCR and other biochemical analyses.
Results:
The rats that received scopoletin treatment demonstrated a significant attenuation in neurological deficits, neurodegeneration markers expression (TREM-1, SERPINE-1), and restored cerebral edema compared to ICH animals. On the other hand, an upsurge in inflammatory cytokines, for example, TNF-α, IL-13, IL-1β, and IL-17, was observed in ICH rats and was reduced to the level near normalcy in the scopoletin-treated groups.
Conclusion:
Our investigations propose that the effectiveness of scopoletin in improving acute neurological function after ICH is promising, and this could be a lead molecule for the development of treatment plans in ICH treatment.
More Related Videos
09:41Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021